These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16987069)

  • 1. Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1.
    Zhao B; Jin NY; Wang RL; Zhang LS; Zhang YJ
    Viral Immunol; 2006; 19(3):518-24. PubMed ID: 16987069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
    Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY
    Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
    Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.
    He H; Tang Y; Qin X; Xu W; Wang Y; Liu X; Liu X; Xiong S; Li J; Zhang M; Duan M
    DNA Cell Biol; 2005 Aug; 24(8):516-20. PubMed ID: 16101350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
    Martin JE; Louder MK; Holman LA; Gordon IJ; Enama ME; Larkin BD; Andrews CA; Vogel L; Koup RA; Roederer M; Bailer RT; Gomez PL; Nason M; Mascola JR; Nabel GJ; Graham BS;
    Vaccine; 2008 Nov; 26(50):6338-43. PubMed ID: 18824060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.
    Zhao K; Yang B; Xu Y; Wu C
    Vaccine; 2010 Sep; 28(41):6666-74. PubMed ID: 20709007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.
    Wang S; Chou TH; Sakhatskyy PV; Huang S; Lawrence JM; Cao H; Huang X; Lu S
    J Virol; 2005 Feb; 79(3):1906-10. PubMed ID: 15650214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif.
    Poh WP; Narasaraju T; Pereira NA; Zhong F; Phoon MC; Macary PA; Wong SH; Lu J; Koh DR; Chow VT
    J Med Virol; 2009 Jul; 81(7):1131-9. PubMed ID: 19475608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus.
    Guo Y; Sun S; Wang K; Zhang S; Zhu W; Chen Z
    DNA Cell Biol; 2005 Aug; 24(8):510-5. PubMed ID: 16101349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
    Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
    BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes.
    Zhou M; Xu D; Li X; Li H; Shan M; Tang J; Wang M; Wang FS; Zhu X; Tao H; He W; Tien P; Gao GF
    J Immunol; 2006 Aug; 177(4):2138-45. PubMed ID: 16887973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
    Shim BS; Stadler K; Nguyen HH; Yun CH; Kim DW; Chang J; Czerkinsky C; Song MK
    Virol J; 2012 Sep; 9():215. PubMed ID: 22995185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.